Skip to main content
Have a personal or library account? Click to login
Fumonisin B1 Neurotoxicity in Young Carp (Cyprinus Carpio L.) Cover

Fumonisin B1 Neurotoxicity in Young Carp (Cyprinus Carpio L.)

Open Access
|Jan 2010

References

  1. Ince PG, Codd GA. Return of the cycad hypothesis - does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health?2005;31:345-53.
  2. Sonnen JA, Larson EB, Gray SL, Wilson A, Kohama SG, Crane PK, Breitner JC, Montine TJ. Free radical damage to cerebral cortex in Alzheimer's disease, microvascular brain injury, and smoking.2009;65:226-9.
  3. Hirsch-Reinshagen V, Burgess BL, Wellington CL. Why lipids are important for Alzheimer disease?2009;326:121-9.
  4. Letenneur L, Pérès K, Fleury H, Garrigue I, Barberger-Gateau P, Helmer C, Orgogozo JM, Gauthier S, Dartigues JF. Seropositivity to herpes simplex virus antibodies and risk of Alzheimer's disease: a population-based cohort study.2008;3:e3637.
  5. Brar S, Henderson D, Schenck J, Zimmerman EA. Iron accumulation in the substantia nigra of patients with Alzheimer disease and parkinsonism.2009;66:371-4.
  6. Luquin MR, Obeso JA, Herrero MT, Laguna J, Martínez-Lage J. Parkinsonismo inducido por MPTP como modelo experimental de enfermedad de Parkinson: Similitudes y difernencias [Parkinsonism induced by MPTP as an experimental model of Parkinson disease: Similarities and differences, in Spanish].1991;6:287-94.
  7. Fuentes JA, Longo VG. An investigation on the central effects of harmine, harmaline and related beta-carbolines.1971;10:15-23.
  8. Barragan LA, Delhaye-Bouchaud N, Laget P. Druginduced activation of the inferior olivary nucleus in young rabbits. Differential effects of harmaline and quipazine.1985;24:645-54.
  9. Schinkel AH, Smit JJ, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol CAAM, van der Valk MA, Robanus-Maandag EC, te Riele HPJ, Berns AJM, Borst P. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs.1994;77:491-502.
  10. Rubin LL, Staddon JM. The cell biology of the blood-brain barrier.1999;22:11-28.
  11. Bradbury MWB, editor. The Concept of a Blood-Brain Barrier. 1ed. Chichester: John Wiley; 1979.
  12. Gelderblom WC, Jaskiewicz K, Marasas WF, Thiel PG, Horak RM, Vleggaar R, Kriek NP. Fumonisins - novel mycotoxins with cancer-promoting activity produced by Fusarium moniliforme.1988;54:1806-11.
  13. Miller JD. Factors that affect the occurrence of fumonisin.2001;109(Suppl 2):321-4.
  14. Merrill AH Jr, Sullards MC, Wang E, Voss KA, Riley RT. Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins.2001;109(Suppl 2):283-9.
  15. Merrill AH Jr, Liotta DC, Riley RT. Fumonisins: fungal toxins that shed light on sphingolipid function.1996;6:218-23.
  16. Kellerman TS, Marasas WF, Thiel PG, Gelderblom WC, Cawood M, Coetzer JA. Leukoencephalomalacia in two horses induced by oral dosing of fumonisin B1.1990;57:269-75.
  17. Colvin BM, Harrison LR. Fumonisin-induced pulmonary edema and hydrothorax in swine.1992;117:79-82.
  18. Dutton MF. Fumonisins, mycotoxins of increasing importance: their nature and their effects.1996;70:137-61.
  19. Shephard GS, Thiel PG, Sydenham EW, Alberts JF, Gelderblom WC. Fate of a single dose of the 14C-labelled mycotoxin, fumonisin B1, in rats.1992;30:768-70.
  20. Voss KA, Bacon CW, Norred WP, Chapin RE, Chamberlain WJ, Plattner RD, Meredith FI. Studies on the reproductive effects of Fusarium moniliforme culture material in rats and the biodistribution of [14C] fumonisin B1 in pregnant rats.1996;4:24-33.
  21. Brown DW, McCoy CP, Rottinghaus GE. Experimental feeding of Fusarium moniliforme culture material containing fumonisin B1 to channel catfish, Ictalurus punctatus.1994;6:123-4.
  22. Rapoport SI, Matthews K, Thompson HK, Pettigrew KD. Osmotic opening of the blood-brain barrier in the rhesus monkey without measurable brain edema.1977;136:23-9.
  23. Lillie RD, editor. Histopathologic Technic and Practical Histochemistry. 3rd ed. New York (NY): McGraw-Hill Book Co.; 1965.
  24. Scheinker IM. Cerebral swelling: Histopathology, classification and clinical significance of brain edema.1947;4:255-75.
  25. Long DM, Hartmann JF, French LA. The ultrastructure of human cerebral edema.1966;25:373-95.
  26. Riley RT, Wang E, Schroeder JJ, Smith ER, Plattner RD, Abbas H, Yoo HS, Merrill AH Jr. Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisins.1996;4:3-15.
  27. Marasas WFO, Kellerman TS, Gelderblom WCA, Coetzer JAW, Thiel PG, van der Lugt JJ. Leukoencephalomalacia in a horse induced by fumonsin B1 isolated from Fusarium moniliforme.1988;55:197-203.
  28. Harrison LR, Colvin BM, Greene JT, Newman LE, Cole Jr, JR. Pulmonary edema and hydrothorax in swine produced by fumonisin B1, a toxic metabolite of Fusarium moniliforme.1990;2:217-21.
  29. Tsunoda M, Dugyala RR, Sharma RP. Fumonisin B1-induced increases in neurotransmitter metabolite levels in different brain regions of BALB/c mice.1998;120(3):457-465
  30. Kwon OS, Sandberg JA, Slikker W, Jr. Effects of fumonisin B1 treatment on blood-brain barrier transfer in developing rats.1997;19(2):151-155
  31. Lumlertdacha S, Lovell RT, Shelby RA, Lenz SD, Kemppainen BW. Growth, hematology and histopathology of channel catfish, Ictalurus punctatus, fed toxins from F. moniliforme.1995;130:201-18.
  32. Marshall WJ, Bangert SK, editors. Clinical Biochemistry: Metabolic and Clinical Aspects. 2nd ed. Edinburgh:; 2008.
  33. Sharma RP, Bhandari N, Tsunoda M, Riley RT, Voss KA, Meredith FI. Fumonisin toxicity in a transgenic mouse model lacking the mdr1a/1b P-glycoprotein genes.2000;8:173-82.
  34. Osuchowski MF, He Q, Sharma RP. Endotoxin exposure alters brain and liver effects of fumonisin B1 in BALB/c mice: implication of blood brain barrier.2005;43:1389-97.
  35. Zanic-Grubisic T, Santini A, Cepelak I, Barisic K, Juretic D, Pepeljnjak S. Influence of ochratoxin A treatment on the activity of membrane bound enzymes in rat brain regions.1996;377:121-7.
  36. Belmadani A, Tramu G, Betbeder AM, Steyn PS, Creppy EE. Regional selectivity to ochratoxin A, distribution and cytotoxicity in rat brain.1998;72:656-62.
  37. Wu SN, Chen H, Liu YC, Chiang HT. Block of L-type Ca2+ current by beauvericin, a toxic cyclopeptide, in the NG108-15 neuronal cell line.2002;15:854-60.
  38. Jestoi M. Emerging fusarium-mycotoxins fusaproliferin, beauvericin, enniatins, and moniliformin: a review.2008;48:21-49.
  39. Osuchowski MF, Edwards GL, Sharma RP. Fumonisin B1-induced neurodegeneration in mice after intracerebroventricular infusion is concurrent with disruption of sphingolipid metabolism and activation of proinflammatory signaling.2005;26:212-21.
  40. Kwon OS, Schmued LC, Slikker W Jr. Fumonisin B1 in developing rats alters brain sphinganine levels and myelination.1997;18:571-9.
  41. Sunyer J. The neurological effects of air pollution in children.2008;32:535-7.
DOI: https://doi.org/10.2478/10004-1254-60-2009-1974 | Journal eISSN: 1848-6312 (formerly 0004-1254) | Journal ISSN: 0004-1254
Language: English, Croatian
Page range: 419 - 426
Published on: Jan 7, 2010
Published by: Institute for Medical Research and Occupational Health
In partnership with: Paradigm Publishing Services

© 2010 Sanja Kovačić, Stjepan Pepeljnjak, Zdravko Petrinec, Maja Klarić, published by Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons License.